Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Walter Gwang-Up Park

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-8187-4188; OpenAlex author ID A5081780284; NIH RePORTER profile ID 10649326. Sources: OpenAlex.

Their work

Papers
21 (first author 1, last author 3)
Trials
0
Grants
3
Labs led
1
Collaborators
107
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 3 papers · 2020: 4 papers · 2021: 1 grant · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper, 1 grant · 2025: 2 papers, 1 grant · 2026: 6 papers

Papers 21

  1. Diabetes secondary to chronic pancreatitis and pancreatic cancer: Observations from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancrea… Co-author DOI 10.1016/j.pan.2026.04.001↗
  2. Towards early detection of pancreatic cancer: The current status of cohort studies by the Diabetes-Pancreatic Ductal AdenoCarcinoma Working Group. Co-author DOI 10.1016/j.pan.2026.04.020↗
  3. Outcomes of pancreatic cancer surveillance among high-risk individuals at a tertiary care academic center. Last author DOI 10.1016/j.pan.2026.06.006↗
  4. Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2025.08.034↗
  5. Adult Chronic Pancreatitis Working Group: Goals, Accomplishments and the Path Ahead. A Report From the Consortium for the Study of Chronic Pancreatitis, Diabet… Co-author DOI 10.1097/mpa.0000000000002657↗
  6. The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma from High-Risk Controls: A Retrospective S… Co-author DOI 10.3390/jcm15197355↗
  7. Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis. Co-author DOI 10.1007/s00125-025-06543-y↗
  8. Suboptimal adherence to surveillance in high-risk individuals for pancreatic cancer at a tertiary care academic center: Lessons from real-world surveillance pa… Last author DOI 10.1016/j.pan.2025.05.002↗
  9. Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics. Co-author DOI 10.1038/s41467-024-54761-6↗
  10. A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising… Co-author DOI 10.1097/sla.0000000000005904↗
  11. Pilot-phase PET/CT study targeting integrin αvβ6 in pancreatic cancer patients using the cystine-knot peptide-based 18F-FP-R01-MG-F2. Co-author DOI 10.1007/s00259-021-05595-7↗
  12. Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and w… Co-author DOI 10.1016/j.pan.2019.11.008↗
  13. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAP… Co-author DOI 10.1136/gutjnl-2019-319352↗
  14. Correction: Management of patients with increased risk for familial pancreatic cancer: updated recommendations for the international cancer of the pancreas scr… Co-author DOI 10.1136/gutjnl-2019-319352corr1↗
  15. Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Ea… Co-author DOI 10.3389/fonc.2020.596931↗
  16. Magnetic resonance imaging as a non-invasive method for the assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for t… Co-author DOI 10.1007/s00261-019-02049-5↗
  17. Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.gie.2018.08.029↗
  18. Reporting Standards for Chronic Pancreatitis by Using CT, MRI, and MR Cholangiopancreatography: The Consortium for the Study of Chronic Pancreatitis, Diabetes,… Co-author DOI 10.1148/radiol.2018181353↗
  19. A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001169↗
  20. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the … First author DOI 10.1097/mpa.0000000000001170↗
  21. Screening for pancreatic cancer: what can cyst fluid analysis tell us? Co-author DOI 10.3410/m3-3↗

Grants 3

  1. Administrative and Biostatistics Core P01CA244114↗
  2. The Stanford Clinical Center for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer U01DK108300↗
  3. Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma U01CA210020↗

Closest collaborators

The 25 strongest of 107 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Randall E. Brand · 9 shared papers, 2018–2026 · strength 1.35
  2. Seung K Kim · 2 shared grants, 2024–2025 · strength 1.29
  3. Phil A. Hart · 6 shared papers, 2018–2026 · strength 1.05
  4. Dhiraj Yadav · 7 shared papers, 2018–2026 · strength 1.01
  5. Evan L Fogel · 6 shared papers, 2018–2026 · strength 0.95
  6. Stephen Jacob Pandol · 6 shared papers, 2018–2026 · strength 0.93
  7. Aida Habtezion · 2 shared papers, 1 shared grant, 2018–2024 · strength 0.89
  8. Andrei Iagaru · 2 shared papers, 1 shared grant, 2021–2024 · strength 0.86
  9. Dana K. Andersen · 4 shared papers, 2020–2026 · strength 0.78
  10. Christopher E Forsmark · 4 shared papers, 2018–2026 · strength 0.78
  11. Laura D Attardi · 1 shared paper, 1 shared grant, 2024–2025 · strength 0.73
  12. Melena D. Bellin · 3 shared papers, 2025–2026 · strength 0.68
  13. Fay Kastrinos · 4 shared papers, 2020–2026 · strength 0.65
  14. José Serrano · 5 shared papers, 2018–2026 · strength 0.64
  15. Alice A. Lee · 2 shared papers, 2025–2026 · strength 0.63
  16. Garry Nolan · 1 shared grant, 2025 · strength 0.57
  17. Steven E Artandi · 1 shared grant, 2025 · strength 0.57
  18. Edgar G. Engleman · 1 shared grant, 2025 · strength 0.57
  19. Mara H. Sherman · 1 shared grant, 2025 · strength 0.57
  20. William E Fisher · 2 shared papers, 2026 · strength 0.49
  21. Norma Alonzo Palma · 2 shared papers, 2026 · strength 0.49
  22. Lisa A. Ford · 2 shared papers, 2026 · strength 0.49
  23. Thomas Charles King · 2 shared papers, 2026 · strength 0.49
  24. Rosalie C. Sears · 2 shared papers, 2026 · strength 0.49
  25. Sonia S. Kupfer · 2 shared papers, 2026 · strength 0.49

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.